Profile picture for user kakutz0

Kelly Meulendyke, PhD

Connect

kakutz0@uky.edu
741 S. Limestone, BBSRB B034A

Positions

  • Scientific Grant Writer

College Unit(s)

Biography and Education

Biography

As the inaugural Scientific Grant Writer in the College of Medicine Office of Research, Kelly's mission is to facilitate grant acquisition by supporting grant development, grant editing, familiarizing researchers with the submission process, and connecting researchers with the myriad of grant development resources available here at the University. Prior to joining the Office of Research, Kelly cultivated diverse experience across basic science and clinical research. She has scientific experience in the areas of mineralized bone histology and the pathogenesis of HIV-associated neurocognitive disorders.

Education

  • Postdoctoral Researcher, Molecular and Comparative Pathobiology Department, Johns Hopkins University, School of Medicine, 2011-2014
  • PhD, Cellular and Molecular Medicine, Johns Hopkins University, School of Medicine, 2011
  • BS, Agricultural Biotechnology, University of Kentucky, College of Agriculture, 2004

Selected Publications

  1. Drewes JL, Meulendyke KA, Liao Z, Witwer KW, Gama L, Ubaida-Mohien C, Li M, Notarangelo FM, Tarwater PM, Schwarcz R, Graham DR, Zink MC. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. Journal of Neurovirology. 2015 Aug;21(4):449-63.

  2. Meulendyke KA, Queen SE, Engle EL, Shirk EN, Liu J, Steiner JP, Nath A, Tarwater PM, Graham DR, Mankowski JL, Zink MC. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. Journal of Neurovirology. 2014 Dec;20(6):591-602.

  3. Meulendyke KA, Croteau JD, Zink MC. HIV life cycle, innate immunity and autophagy in the central nervous system. Current Opinion in HIV and AIDS. 2014 Nov;9(6):565-71.

  4. Meulendyke KA, Ubaida-Mohien C, Drewes JL, Liao Z, Gama L, Witwer KW, Graham DR, Zink MC. Elevated brain monoamine oxidase in SIV/HIV CNS disease. Journal of Infectious Diseases. 2014 Sep;210(6):904-12.

  5. Meulendyke KA, Pletnikov MV, Engle EL, Tarwater PM, Graham DR, and Zink MC. Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease. Journal of Neuroimmune Pharmacology. 2012 Jun;7(2):454-64.

  6. Weed M, Adams RJ, Hienz RD, Meulendyke KA, Linde ME, Clements JE, Mankowski JL, and Zink MC. SIV/Macaque model of HIV infection in cocaine users: Minimal effects of cocaine on behavior, virus replication, and CNS inflammation. Journal of Neuroimmune Pharmacology. 2012 Jun;7(2):401-11.

  7. Meulendyke KA, Wurth MA, McCann RO, and Dutch RE. Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein.  Journal of Virology. 2005 Oct;79(20):12643-9.

PubMed Publications